MENU

NTLA Intellia Therapeutics Forecast, Technical & Fundamental Analysis

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
NTLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
NTLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NTLA is expected to report earnings to -80 cents per share on November 05

Intellia Therapeutics NTLA Stock Earnings Reports
Q3'26
Est.
$-0.80
Q2'26
Est.
$-0.80
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.09
The last earnings report on August 06 showed earnings per share of -80 cents, meeting the estimate of -80 cents. With 2.76M shares outstanding, the current market capitalization sits at 1.60B.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAR371.502.20
+0.60%
Marriott International
RUSHA44.480.11
+0.25%
Rush Enterprises
HHS4.37N/A
N/A
Harte Hanks
ISBA36.86-0.59
-1.58%
Isabella Bank Corporation
IMTX6.83-0.38
-5.27%
Immatics NV

NTLA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-5.33%
VCYT - NTLA
69%
Closely correlated
-2.07%
CRSP - NTLA
63%
Loosely correlated
-2.81%
BEAM - NTLA
60%
Loosely correlated
-2.79%
EDIT - NTLA
59%
Loosely correlated
-11.09%
AXON - NTLA
55%
Loosely correlated
-0.26%
More
A.I. Advisor
published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
377
Web
https://www.intelliatx.com
Intellia Therapeutics (NTLA) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com